H929 MM cells co-cultured with the bone marrow stromal cell line HS-5 showed resistance to SNS-032, which suggests that bone marrow stroma may play a pivotal role in the development of primary resistance to CDK9-targeted treatment. This evidence concerns the gene CDK9 and Miyoshi myopathy.